The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Relative risk of cardiovascular disease among people living with HIV : a systematic review and meta‐analysis
Open accessAbstract
Objectives: The aim of this study was to estimate the relative risk of cardiovascular disease ( CVD ) among people living with HIV ( PLHIV ) compared with the HIV ‐uninfected population. Methods: We conducted a systematic review and meta‐analysis of studies from the peer‐reviewed literature. We searched the M edline database for relevant journal articles published before A ugust 2010. Eligible studies were observational and randomized controlled trials, reporting CVD , defined as myocardial infarction ( MI ), ischaemic heart disease, cardiovascular and cerebrovascular events or coronary heart disease among HIV ‐positive adults. Pooled relative risks were calculated for various groupings, including different classes of antiretroviral therapy ( ART ). Results: The relative risk of CVD was 1.61 [95% confidence interval ( CI ) 1.43–1.81] among PLHIV without ART compared with HIV ‐uninfected people. The relative risk of CVD was 2.00 (95% CI 1.70–2.37) among PLHIV on ART compared with HIV ‐uninfected people and 1.52 (95% CI 1.35–1.70) compared with treatment‐naïve PLHIV . We estimate the relative risk of CVD associated with protease inhibitor ( PI )‐, nucleoside reverse transcriptase inhibitor‐ and nonnucleoside reverse transcriptase inhibitor‐based ART to be 1.11 (95% CI 1.05–1.17), 1.05 (95% CI 1.01–1.10) and 1.04 (95% CI 0.99–1.09) per year of exposure, respectively. Not all ART was associated with increased risk; specifically, lopinavir/ritonavir and abacavir were associated with the greater risk and the relative risk of MI for PI ‐based versus non‐ PI ‐based ART was 1.41 (95% CI 1.20–1.65). Conclusion: PLHIV are at increased risk of cardiovascular disease. Although effective in prolonging survival, ART (in particular PI ‐based regimens) is related to further increased risk of CVD events among people at highest initial absolute risk of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIV patients have been found to have a higher risk of cardiovascular events, which was even higher in patients treated with protease inhibitors (Friis‐Moller et al, 2007; Islam et al, 2012; Shah et al, 2018).”
From The struggle of a good friend getting old: cellular senescence in viral responses and therapy (2021) · cites this paper as Islam et al, 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
Cook, D. J., Mulrow, C. D., & Haynes, R. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-5-199703010-00006 · Cited by 2,184
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Treatment for Adult HIV Infection
Hammer, S. M., Saag, M. S., Schechter, M., Montaner, J. S. G., Schooley, R. T., Jacobsen, D. M., Thompson, M., Carpenter, C. C. J., Fischl, M. A., Gazzard, B., et al. (2006) · JAMA · doi:10.1001/jama.296.7.827 · Cited by 1,034
D'Agostino, R. B., Lee, M., Belanger, A. J., Cupples, L. A., Anderson, K., & Kannel, W. B. (1990) · Statistics in Medicine · doi:10.1002/sim.4780091214 · Cited by 798
Worm, S. W., Sabin, C. A., Weber, R. K., Reiss, P., El-Sadr, W. M., Dabis, F., Wit, S. D., Law, M. G., Monforte, A. D., Friis‐Møller, N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/649897 · Cited by 644
Mary‐Krause, M., Cotte, L., Simon, A., Partisani, M., & Costagliola, D. G. (2003) · AIDS · doi:10.1097/00002030-200311210-00010 · Cited by 563
Coronary Heart Disease in HIV-Infected Individuals
Currier, J. S., Taylor, A., Boyd, F., Dezii, C. M., Kawabata, H., Burtcel, B., Maa, J., & Hodder, S. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308010-00012 · Cited by 534
Löllgen, H., Böckenhoff, A., & Knapp, G. (2009) · International Journal of Sports Medicine · doi:10.1055/s-0028-1128150 · Cited by 529
Klein, D., Hurley, L. B., Quesenberry, C. P., & Sidney, S. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200208150-00002 · Cited by 418
Obel, N., Thomsen, H. F., Kronborg, G., Larsen, C. S., Hildebrandt, P. R., Sørensen, H. T., & Gerstoft, J. (2007) · Clinical Infectious Diseases · doi:10.1086/518285 · Cited by 331
Lang, S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.197 · Cited by 303
Low CD4+T Cell Count Is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study
Lichtenstein, K. A., Armon, C., Buchacz, K. A., Chmiel, J. S., Buckner, K., Tedaldi, E., Wood, K. C., Holmberg, S. D., & Brooks, J. T. (2010) · Clinical Infectious Diseases · doi:10.1086/655144 · Cited by 300
Lang, S., Mary‐Krause, M., Cotte, L., Gilquin, J., Partisani, M., Simon, A., Boccara, F., Bingham, A., & Costagliola, D. G. (2010) · AIDS · doi:10.1097/qad.0b013e328339192f · Cited by 297
Phillips, A. N., Carr, A. D., Neuhaus, J., Visnegarwala, F., Prineas, R. J., Burman, W. J., Williams, I. G., Drummond, F., Duprez, D. A., Belloso, W. H., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300215 · Cited by 240
Martin, A. M., Bloch, M., Amin, J., Baker, D., Cooper, D. A., Emery, S., & Carr, A. D. (2009) · Clinical Infectious Diseases · doi:10.1086/644769 · Cited by 222
Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
Choi, A. I., Vittinghoff, E., Deeks, S. G., Weekley, C. C., Li, Y., & Shlipak, M. G. (2011) · AIDS · doi:10.1097/qad.0b013e328347fa16 · Cited by 156
Abacavir use and cardiovascular disease events
Cruciani, M., Zanichelli, V., Serpelloni, G., Bosco, O., Malena, M., Mazzi, R., Mengoli, C., Parisi, S. G., & Moyle, G. J. (2011) · AIDS · doi:10.1097/qad.0b013e328349c6ee · Cited by 154
Obel, N., Farkas, D. K., Kronborg, G., Larsen, C. S., Pedersen, G., Riis, A. H., Pedersen, C. D., Gerstoft, J., & Sørensen, H. T. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00751.x · Cited by 143
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV‐infected patients
Iloeje, U., Yuan, Y., L’Italien, G. J., Mauskopf, J., Holmberg, S. D., Moorman, A. C., Wood, K., & Moore, R. D. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00265.x · Cited by 137
Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator
Böhning, D. (2002) · Biostatistics · doi:10.1093/biostatistics/3.4.445 · Cited by 122
Bozzette, S. A., Ake, C. F., Tam, H. K., Phippard, A. E., Cohen, D., Scharfstein, D. O., & Louis, T. A. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815e7251 · Cited by 115
Bárbaro, G., Lorenzo, G. D., Cirelli, A., Grisorio, B., Lucchini, A., Hazra, C., & Barbarini, G. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80283-7 · Cited by 91
Cockerham, L. R., Scherzer, R., Zolopa, A. R., Rimland, D., Lewis, C. E., Bacchetti, P., Grünfeld, C., Shlipak, M. G., & Tien, P. C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b79d22 · Cited by 85
COPLAN, P. M., Nikas, A. A., Japour, A. J., Cormier, K., Kremers, H. M., Lewis, R., Xu, Y., & DiNubile, M. J. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203766774487 · Cited by 61
Aboud, M., Elgalib, A., Pomeroy, L., Panayiotakopoulos, G. D., Skopelitis, E. E., Kulasegaram, R., Dimian, C., Lampe, F. C., Duncan, A., Wierzbicki, A. S., et al. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02424.x · Cited by 51
Kwong, G. P. S., Ghani, A. C., Rode, R. A., Bartley, L. M., Cowling, B. J., da Silva, B., Donnelly, C. A., van Sighem, A., Cameron, D. W., Danner, S. A., et al. (2006) · AIDS · doi:10.1097/01.aids.0000247115.81832.a1 · Cited by 47
Domingo, P., Suárez-Lozano, I., Teira, R., Fernando, L., Terrón, A., Pompeyo, V., Juan, G., José, G. M., Geijo, P., Vergara, A., et al. (2008) · The Open AIDS Journal · doi:10.2174/1874613600802010026 · Cited by 34
Vaughn, G. S., & Detels, R. (2007) · AIDS Care · doi:10.1080/09540120701203329 · Cited by 24
Risk factors for myocardial infarction in HIV-positive patients
Quirós-Roldán, E., Torti, C., Tinelli, C., Moretti, F., Zanini, B., Tirelli, V., Pan, A., Casari, S., & Carosi, G. (2005) · International Journal of STD & AIDS · doi:10.1258/0956462052932665 · Cited by 3
Research works printed but not linked: 6
- UNAIDS, 2010, Global report: UNAIDS report on the global AIDS epidemic 2010
- BedimoR WestfallA DrechslerH TebasP editors.Abacavir use and risk of acute myocardial infarction and cerebrovascular disease in the HAART era.5th IAS Conference on HIV Pathogenesis and Treatment. Cape Town South Africa 2009[Abstract MOAB202].
- BenitoR PinillaJ LabargaPet al. editors.Comparison of cardiovascular risk factors between HIV‐infected patients and non‐infected general population.The 14th International AIDS Conference. Barcelona Spain July2002[Abstract B10290].
- DurandM SheehyO BarilJ‐G LelorierJ TremblayC editors.Relation between use of nucleoside reverse transcriptase inhibitors (NRTI) and risk of myocardial infarction (MI): a nested case control study using Quebec's public health insurance database (QPHID).5th IAS Conference on HIV Pathogenesis and Treatment. Cape Town South Africa 2009[Abstract TUPEB175].
- HolmbergSD MoormanAC TongTCet al. editors.Protease inhibitor drug use and adverse cardiovascular events in ambulatory HIV‐infected patients.The 14th International AIDS Conference. Barcelona Spain July2002[Abstract TuPeB4494].
- KleinD HurleyL SilverbergM HorbergM QuesenberryC SidneyS editors.Surveillance Data for Myocardial Infarction Hospitalizations among HIV+ and HIV‐ Northern Californians: 1994–2006.14th Conference on Retroviruses and Opportunistic Infections. Los Angeles CA February 2007 [Abstract 807].
Cited by
Sorted by citations
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Shah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033369 · Cited by 975
The global burden of multiple chronic conditions: A narrative review
Hajat, C., & Stein, E. M. (2018) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2018.10.008 · Cited by 1,046
“81) for HIV patients compared to HIVuninfected people (Islam et al., 2012).”
BackgroundESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Metadata
- Authors
- Islam, F., Wu, J., Jansson, J., & Wilson, D.
- Affiliations
- The Kirby Institute Faculty of Medicine University of New South Wales Sydney NSW Australia
- UNSW Sydney (AU)
- Corresponding author
- Wilson, DP
- ORCID
- Venue
- HIV Medicine
- Publisher
- Wiley
- Published
- 2012-03-14
- Volume
- 13
- Issue
- 8
- Pages
- 453-468
- ISSN
- 1464-2662 (ISSN-L)
- 1468-1293
- OpenAlex
- W1677033108
- Cited by
- 432
- References
- 40
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 28 · 2023: 19 · 2022: 31 · 2021: 39 · 2020: 42 · 2019: 28 · 2018: 44 · 2017: 34 · 2016: 40 · 2015: 29 · 2014: 27 · 2013: 26 · 2012: 15
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- HIV Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Government
- Medical Research Council
- Australian Research Council (DP1093026, FT0991990)
- National Health and Medical Research Council (630495)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- cardiovascular disease, people living with HIV, antiretroviral therapy, protease inhibitors, myocardial infarction, ischemic heart disease, coronary artery disease, cerebrovascular events, lopinavir/ritonavir, abacavir, cardiovascular risk
- MeSH terms
- Adult, Cardiovascular Diseases, Humans, Protease Inhibitors, Risk Factors, HIV Infections, Incidence, Reverse Transcriptase Inhibitors, Anti-Retroviral Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
